An interventional study of Isometric Exercise Training (IET) and Expectation-Enhancing Informational Framing in Hypertension, Elevated Blood Pressure and Sedentary Lifestlye, sponsored by Canterbury Christ Church University. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-16.
Sponsored by Canterbury Christ Church University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 223 studies in Hypertension with a site in United Kingdom — 34 open to participants now, 43 under way, 7 of them phase 3. Hypertension · United Kingdom.
Among the 223 studies in Hypertension with a site in United Kingdom, this one is the 135th largest by planned enrollment of the 172 interventional ones that give a count, is one of 13 that started in 2025, is one of 73 with no phase, reaches primary completion later than 8 of the 42 other live ones, and was the 209th registered.
6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.
Browse Hypertension studies →34 of the 223 studies in Hypertension with a site in United Kingdom are open now. Recruiting first, the newest first:
CRISPR Therapeutics AG · Sites in United Kingdom, United States, Australia
Ages 18–75
King's College London · Sites in United Kingdom
Ages 10–25 · Healthy volunteers
Northumbria University · Sites in United Kingdom
Ages 18+
Cambridge University Hospitals NHS Foundation Trust · Sites in United Kingdom
Ages 18–40
Medtronic Vascular · Sites in United Kingdom, Australia, Belgium and 6 more countries
Ages 18+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.
This study: 18 Years to 55 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
223 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 27 · Phase 3 48 · Phase 4 20
First in 1997; this study’s year is marked. 13 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 36 is below the median of 100 across 4,585 interventional studies indexed under Hypertension.
Median enrollment 125 across the 172 interventional studies, 200 across the 50 observational. Of the 156 that completed or were terminated, 52 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
97 of 223 have an industry lead sponsor. The 10 most frequent:
Canterbury Christ Church University is the lead sponsor of 27 studies on the registry; 5 are open to participants now.
Canterbury Christ Church University has 2 studies filed under Hypertension — fewer than ten, so there is no comparison to draw.
11 of the studies in Hypertension with a site in United Kingdom that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03683186Phase 3United TherapeuticsA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | 2026-12 |
| NCT07222917AstraZenecaA Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. | 2026-12-10 |
| NCT07294794University of BirminghamPersonalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension | 2026-12-31 |
| NCT06059638Orchestra BioMed, IncBradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | 2027-01 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 223 studies in Hypertension with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study investigates how isometric exercise training (IET) affects blood pressure in physically inactive adults. Isometric exercise involves sustained muscle contractions without movement-for example, pushing against a fixed object. Previous research has shown that IET may help reduce blood pressure, but the mechanisms involved are not fully understood.
The purpose of this study is to assess both the immediate (acute) and long-term (chronic) effects of IET on cardiovascular outcomes. Participants will complete a series of lab-based exercise sessions over several weeks. In these sessions, they will perform repeated bouts of isometric leg extensions while seated on an exercise machine designed to measure muscle force.
Throughout the study, researchers will monitor participants' blood pressure, heart rate, and muscle activity. Acute responses-such as post-exercise hypotension (a short-term drop in blood pressure)-will be measured immediately after exercise. Chronic changes, such as resting blood pressure improvements, will be evaluated across the training period.
Additional measurements will include heart rate variability (HRV), which gives insight into autonomic nervous system activity, and electromyography (EMG), which tracks muscle fatigue and activation patterns. These data will help explore potential mechanisms behind the cardiovascular benefits of IET.
By examining how repeated sessions of isometric exercise influence blood pressure and related physiological responses, this research may support the use of IET as a non-pharmacological strategy for managing or preventing hypertension in physically inactive individuals.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group complete repeated isometric exercise training sessions. Prior to training, they receive a neutral informational presentation about isometric exercise, which does not mention blood pressure or cardiovascular benefits. The exercise consists of bilateral isometric leg extensions on a dynamometer. Cardiovascular and neuromuscular outcomes, including blood pressure, heart rate variability, and muscle fatigue, are monitored throughout the intervention period.
Behavioral: Isometric Exercise Training (IET)
Participants in this group complete repeated isometric exercise training sessions. Prior to training, they receive an expectation-enhancing informational presentation that emphasizes the effectiveness of isometric exercise as a non-pharmacological intervention for reducing blood pressure. The exercise consists of bilateral isometric leg extensions on a dynamometer. Blood pressure, heart rate variability, and muscle activity are assessed to determine physiological responses to the intervention.
Behavioral: Isometric Exercise Training (IET) · Behavioral: Expectation-Enhancing Informational Framing
Participants in this group do not receive any intervention or educational presentation. They attend study visits for assessment purposes only. Measurements include resting blood pressure, heart rate variability, and muscle activity, allowing for comparison with the intervention groups to evaluate the effects of isometric exercise training.
Participants perform four repetitions of 90 degree bilateral isometric leg extensions on a dynamometer at 30% of their maximum voluntary contraction (MVC). Each contraction is held for 2 minutes, with 2-minute rest intervals between bouts. Sessions are performed three times per week for four weeks. This behavioral intervention is designed to investigate the acute and chronic effects of isometric exercise on blood pressure, heart rate variability, and muscle fatigue.
Also known as: Static Strength Training, Leg Extension Hold Training
Participants receive a brief standardized presentation highlighting isometric exercise as an evidence-based intervention for lowering blood pressure. The presentation includes statements designed to enhance outcome expectations based on prior literature and expert framing.
Change in Resting Systolic Blood Pressure
Systolic blood pressure will be measured at rest using a Task Force Monitor prior to and after the isometric exercise intervention period. The primary outcome is the change in resting systolic blood pressure from baseline to final testing. Measurements are taken in a seated position following standard resting protocols.
Time frame: Baseline to Post-Intervention (approximately 4 weeks)
Change in Diastolic Blood Pressure
Diastolic blood pressure will be assessed in the same manner as systolic. The secondary outcome is the change in diastolic values from baseline to final testing.
Time frame: Baseline to Post-Intervention (approximately 4 weeks)
Post-Exercise Hypotension Response
Post-exercise hypotension will be evaluated as the change in systolic and diastolic blood pressure immediately following each isometric exercise session, compared to pre-exercise baseline.
Time frame: During the first week of the exercise intervention. Sessions 1, 2 and 3.
Change in Heart Rate Variability (HRV)
HRV will be analyzed using Task Force Monitor data to assess autonomic modulation. Measures include time-domain (e.g., RMSSD) and frequency-domain (e.g., LF/HF ratio) indices.
Time frame: Baseline to Post-Intervention (approximately 4 weeks)
Change in Muscle Fatigue Markers (EMG)
Muscle fatigue will be assessed using surface electromyography (EMG) of the vastus lateralis. Fatigue indices include changes in median frequency and torque stability over repeated contractions.
Time frame: Baseline to Post-Intervention (Approximately 4 weeks)
Plan to share: No — This is an early-phase investigator-led study involving a small sample size. At this stage, there are no plans to share individual participant data due to ethical and data governance constraints outlined in the approved protocol. Aggregated results may be shared through publication or presentation.
No publications or documents are linked to this record.
Started Apr 2025 (actual). Primary completion is estimated for Aug 2025, 4 months after the start.
Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 4 months is below that.
Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Canterbury Christ Church University